Carboplatin/Paclitaxel과 한방치료를 병행하며 부분 관해 된 폐전이 동반 말기 난소암 1례
A Case Report of Partial Remission of End-stage Ovarian Cancer Patient with Lung Metastasis Treated with Carboplatin/Paclitaxel and Traditional Korean Medicine
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objectives: The purpose of this study is to report the effect of combination treatment of Traditional Korean medicine (TKM) and chemotherapy on a ovarian cancer with lung metastasis patient. Methods: One ovarian cancer with lung metastasis patient was treated by TKM in conjunction with Carboplatin/paclitaxel since Feb. 2020. Repeat cycle every 3 weeks for 6 times. The patient has been treated with TKM at the same time. To evaluate the patient, symptoms were measured by Numeric Rating Scale (NRS), Eastern Cooperative Oncology Group (ECOG) and tumor size was measured by scanning with Computed Tomography (CT). Blood tests including cancer biomarker were conducted during treatment. Adverse events were evaluated by the National Cancer Institute Common Terminology Criteria for Adverse Event (NCI-CTCAE), version 5.0. Results: After treatment with Carboplatin/paclitaxel and TKM during 2 months, the size of the ovarian cancer was decreased(Partial Response, PR), size and malignant pleural effusion at right lung disappeared. And no evidence of newly developed metastatic lesions. After 2 months, the tumor response was stable disease while improving the performance and other symptoms. Conclusions: This case provides us conjunctive treatment with Conventional and Eastern medicine may have substantial benefit for patients with end-stage ovarian cancer.
Abstract
Objectives: The purpose of this study is to report the effect of combination treatment of Traditional Korean medicine (TKM) and chemotherapy on a ovarian cancer with lung metastasis patient. Methods: One ovarian cancer with lung metastasis patient was treated by TKM in conjunction with Carboplatin/paclitaxel since Feb. 2020. Repeat cycle every 3 weeks for 6 times. The patient has been treated with TKM at the same time. To evaluate the patient, symptoms were measured by Numeric Rating Scale (NRS), Eastern Cooperative Oncology Group (ECOG) and tumor size was measured by scanning with Computed Tomography (CT). Blood tests including cancer biomarker were conducted during treatment. Adverse events were evaluated by the National Cancer Institute Common Terminology Criteria for Adverse Event (NCI-CTCAE), version 5.0. Results: After treatment with Carboplatin/paclitaxel and TKM during 2 months, the size of the ovarian cancer was decreased(Partial Response, PR), size and malignant pleural effusion at right lung disappeared. And no evidence of newly developed metastatic lesions. After 2 months, the tumor response was stable disease while improving the performance and other symptoms. Conclusions: This case provides us conjunctive treatment with Conventional and Eastern medicine may have substantial benefit for patients with end-stage ovarian cancer.
참고문헌 (23)
- Korean Oncology textbook complication committee, "Integrative Oncology of Korean Medicine", pp.357~365 (2017), Gunja Publication
- 김경순, "난소암 치료에 대한 한의 임상 가이드라인", 대한암한의학회지, 21(2), pp.37~50 (2016), 대한암한의학회[DOI]
- "Annual report of cancer statistics in Korea in 2018"[URL]
- Park HM, "Gynecology. 5th rev ed. Korean Society of Obstetrics and Gynecology", pp.809~853 (2018), Korea Medical Book Publishing Co
- "Ovarian cancer, Side Effects of Treatment"[URL]
- 유선영, "항암화학요법을 받는 난소암환자의 수면장애와 우울이 삶의 질에 미치는 영향", Asian Oncology Nursing, 15(4), pp.203~210 (2015), 대한종양간호학회
- Jin YJ, "A Case of Improvement of Metastatic Ovarian and Endometrial Cancer Treated by Integrative Medicine Therapy Combined with Chemotherapy", J of Kor Traditional Oncology, 19(1), pp.33~41 (2014)
- 한가진, "유방암에 대한 한양방 병용 치료 증례 보고 1례", 대한한방내과학회지, 38(5), pp.820~827 (2017), 대한한방내과학회
- 이지현, "근치적 절제술 시행한 난소암 환자에서 항암치료후유증 치험 1례", 대한한방부인과학회지, 27(3), pp.124~134 (2014), 대한한방부인과학회[DOI]
- Jung SH, "Clinical study on each case of secondary lymphedema in ovarian ca. and breast ca. which was cured by lymphmassage", J Korean Obstet Gynecol, 14(2), pp.250~263 (2001)
- Eisenhauer EA, "New response evaluation criteria in solid tumours : Revised RECIST guideline(version 1. 1)", Eur J Cancer, 45(2), pp.228~247 (2009)
- Hawker GA, "Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP)", Arthritis Care and Research, 63(S11), pp.240~252 (2011)
- "Common Terminology Criteria for Adverse Events(CTCAE) v.5.0" (2017)[URL]
- Cho JG, "Oriental clinical oncology", pp.135~ (2005), Jumin Publication
- Kim JM, "Integrated Cancer Treatment Roadmap", pp.47~ (2014), Seohyun publishing
- "Practice Guideline for Ovarian Cancer (ver. 4.0)"[URL]
- Whang DY, "New Bangyakhappyon", pp.139~ (2010), Younglim publishing
- 허만규, "八物湯이 알레르기반응에 미치는 효과", 동의생리병리학회지, 17(4), pp.1075~1081 (2003), 한의병리학회
- Kwon OB, "Effects of Palmul-tang(Bawu-tang)and Kamipalmul-tang(Jiaweibawu-tang)on the Recovery of Fatigue in Rats", Journal of oriental rehabilitation medicine, 12(1), pp.89~100 (2002)
- Textbook Compilation Committee of National Universitiy of Korean Medicine, "Herbology", pp.439~ (1991), Yeonglimsa
- Jang HJ, "Molecular mechanism by which Resina Toxicodendrii induces apoptosis and suppresses chemoresistance in MCF-7", DOX cells, Graduate School of Korean Medicine, Kyunghee University, 2017
- Kwon EM, "A Case of Metastatic Low-grade Endometrial Stromal Sarcoma Patient Managed with Allergen-removed Rhus Verniciflua Stokes Based on Traditional Korean Medicine", J of Kor Traditional Oncology, 16(2), pp.1~8 (2011)
- 최원철, "법제 옻나무 추출물의 혈관형성저해 및 항암효과에 관한 연구", 동의생리병리학회지, 20(4), pp.825~829 (2006), 한의병리학회